Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

NCT02097043 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DA-7218
DRUG: Placebo

Sponsor

Dong-A ST Co., Ltd.